RS49675B - 4"supstituisani-9-deokso-9a-aza-9a- homoeritromicin a derivati - Google Patents

4"supstituisani-9-deokso-9a-aza-9a- homoeritromicin a derivati

Info

Publication number
RS49675B
RS49675B YUP-586/99A YU58699A RS49675B RS 49675 B RS49675 B RS 49675B YU 58699 A YU58699 A YU 58699A RS 49675 B RS49675 B RS 49675B
Authority
RS
Serbia
Prior art keywords
groups
integer
membered heteroaryl
carbon
optionally substituted
Prior art date
Application number
YUP-586/99A
Other languages
English (en)
Serbian (sr)
Inventor
Brian Scott Bronk
Michael Anthony Levatic
Takushi Kaneko
Bingwei Vera Yang
Edward Alan Glazer
Hengmiao Cheng
Original Assignee
Pfizer Products Inc.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21959336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS49675(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Products Inc., filed Critical Pfizer Products Inc.,
Publication of YU58699A publication Critical patent/YU58699A/xx
Publication of RS49675B publication Critical patent/RS49675B/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
YUP-586/99A 1997-06-11 1998-05-29 4"supstituisani-9-deokso-9a-aza-9a- homoeritromicin a derivati RS49675B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4934897P 1997-06-11 1997-06-11
PCT/IB1998/000839 WO1998056802A1 (en) 1997-06-11 1998-05-29 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives

Publications (2)

Publication Number Publication Date
YU58699A YU58699A (US06559137-20030506-C00182.png) 2002-08-12
RS49675B true RS49675B (sr) 2007-11-15

Family

ID=21959336

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-586/99A RS49675B (sr) 1997-06-11 1998-05-29 4"supstituisani-9-deokso-9a-aza-9a- homoeritromicin a derivati

Country Status (50)

Country Link
US (4) US6420536B1 (US06559137-20030506-C00182.png)
EP (1) EP0988310B9 (US06559137-20030506-C00182.png)
JP (2) JP3315704B2 (US06559137-20030506-C00182.png)
KR (1) KR100396168B1 (US06559137-20030506-C00182.png)
CN (4) CN101691390A (US06559137-20030506-C00182.png)
AP (1) AP1231A (US06559137-20030506-C00182.png)
AR (1) AR013086A1 (US06559137-20030506-C00182.png)
AT (1) ATE251173T1 (US06559137-20030506-C00182.png)
AU (1) AU749816B2 (US06559137-20030506-C00182.png)
BG (1) BG64391B1 (US06559137-20030506-C00182.png)
BR (1) BRPI9810519B8 (US06559137-20030506-C00182.png)
CA (1) CA2293823C (US06559137-20030506-C00182.png)
CO (1) CO4950611A1 (US06559137-20030506-C00182.png)
CZ (1) CZ298556B6 (US06559137-20030506-C00182.png)
DE (2) DE122004000018I2 (US06559137-20030506-C00182.png)
DK (1) DK0988310T3 (US06559137-20030506-C00182.png)
DZ (1) DZ2514A1 (US06559137-20030506-C00182.png)
EA (1) EA002441B1 (US06559137-20030506-C00182.png)
EG (1) EG24081A (US06559137-20030506-C00182.png)
ES (1) ES2205487T3 (US06559137-20030506-C00182.png)
FR (1) FR04C0013I2 (US06559137-20030506-C00182.png)
GT (1) GT199800077A (US06559137-20030506-C00182.png)
HK (3) HK1028048A1 (US06559137-20030506-C00182.png)
HN (1) HN1998000086A (US06559137-20030506-C00182.png)
HR (1) HRP980314B1 (US06559137-20030506-C00182.png)
HU (2) HU228005B1 (US06559137-20030506-C00182.png)
ID (1) ID22992A (US06559137-20030506-C00182.png)
IL (1) IL132809A0 (US06559137-20030506-C00182.png)
IS (1) IS1998B (US06559137-20030506-C00182.png)
LU (1) LU91076I9 (US06559137-20030506-C00182.png)
MA (1) MA24564A1 (US06559137-20030506-C00182.png)
ME (1) ME00876B (US06559137-20030506-C00182.png)
MY (1) MY123354A (US06559137-20030506-C00182.png)
NL (1) NL300150I2 (US06559137-20030506-C00182.png)
NO (1) NO316911B1 (US06559137-20030506-C00182.png)
NZ (2) NZ500660A (US06559137-20030506-C00182.png)
OA (1) OA11224A (US06559137-20030506-C00182.png)
PA (1) PA8452201A1 (US06559137-20030506-C00182.png)
PE (1) PE79699A1 (US06559137-20030506-C00182.png)
PL (1) PL191601B1 (US06559137-20030506-C00182.png)
PT (1) PT988310E (US06559137-20030506-C00182.png)
RS (1) RS49675B (US06559137-20030506-C00182.png)
SI (1) SI0988310T1 (US06559137-20030506-C00182.png)
SK (1) SK284171B6 (US06559137-20030506-C00182.png)
TN (1) TNSN98082A1 (US06559137-20030506-C00182.png)
TW (1) TW472060B (US06559137-20030506-C00182.png)
UA (1) UA67744C2 (US06559137-20030506-C00182.png)
UY (1) UY25040A1 (US06559137-20030506-C00182.png)
WO (1) WO1998056802A1 (US06559137-20030506-C00182.png)
ZA (1) ZA985017B (US06559137-20030506-C00182.png)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000086A (es) * 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
WO1999012552A1 (en) * 1997-09-10 1999-03-18 Merck & Co., Inc. 9a-AZALIDES AS VETERINARY ANTIMICROBIAL AGENTS
EP1779853A3 (en) * 1997-09-10 2010-01-27 Merial Ltd. 9a-azalides as veterinary antimicrobial agents
US6339063B1 (en) 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
US6100240A (en) * 1998-10-09 2000-08-08 Pfizer Inc Macrolide derivatives
CA2411293A1 (en) * 1999-01-28 2000-07-28 Pfizer Products Inc. Novel azalides and methods of making same
DK1189912T3 (da) * 1999-05-18 2008-06-30 Pfizer Prod Inc Nye krystallinske former af et makrolid antibiotikum
SK15162001A3 (sk) * 1999-05-24 2003-02-04 Pfizer Products Inc. Deriváty 13-metylerytromycínu
US6465437B1 (en) * 1999-06-30 2002-10-15 Pfizer Inc. Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition
DE60025370T2 (de) * 1999-08-24 2006-09-21 Abbott Laboratories, Abbott Park 9a-azalide mit antibakterieller wirkung
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
PT1250343E (pt) * 2000-01-27 2003-11-28 Pfizer Prod Inc Composicoes de antibioticos de azalida
KR20030031479A (ko) * 2000-04-27 2003-04-21 화이자 프로덕츠 인코포레이티드 포유동물에서 세균 감염 또는 원생생물 감염을 치료 또는 예방하기 위한 아잘라이드 항생제 조성물
BR0209241A (pt) * 2001-04-27 2004-06-15 Pfizer Prod Inc Processo para preparação de derivados de9-deoxo-9a-aza-9a-homoeritromicina a 4-substituida
AU2002317415A1 (en) * 2001-08-01 2003-02-17 Pfizer Products Inc. Azalide antibiotic compositions
CA2529817C (en) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Novel antibacterial agents
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
CA2546195A1 (en) * 2003-11-21 2005-06-02 Pfizer Products Inc. The use of anti biotics as vaccine adjuvants
NZ550464A (en) * 2004-03-16 2010-10-29 Boehringer Ingelheim Int Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
US20080227730A1 (en) * 2005-01-14 2008-09-18 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 9A-Carbamoyl and Thiocarbamoyl Azalides With Antimalarial Activity
JP5698979B2 (ja) * 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド系抗菌剤の調製プロセス
JP5602748B2 (ja) 2008-10-24 2014-10-08 センプラ ファーマシューティカルズ,インコーポレイテッド トリアゾール含有マクロライドを用いた生体防御
US9937194B1 (en) * 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
DK2550286T3 (en) 2010-03-22 2016-02-29 Cempra Pharmaceuticals Inc CRYSTALLINE FORMS OF A MACROLID AND APPLICATIONS THEREOF
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ,インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
ES2532455T3 (es) 2010-09-20 2015-03-27 Novartis Tiergesundheit Ag Nuevo procedimiento de preparación de 9-desoxo-9a-aza-9a-homoeritromicina modificada en el C-4'' del anillo de cladinosa por un grupo epóxido
CA2814333A1 (en) * 2010-10-10 2012-04-19 Synovo Gmbh Anti-inflammatory macrolides
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
CN102260306B (zh) * 2011-07-22 2012-07-18 山东鲁抗舍里乐药业有限公司 一种制备泰拉霉素的方法
WO2013013834A1 (en) 2011-07-27 2013-01-31 Farma Grs, D.O.O. New crystalline forms of tulathromycin
US10188674B2 (en) 2012-03-27 2019-01-29 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
CN102786569B (zh) * 2012-09-07 2016-12-07 安徽中升药业有限公司 泰拉霉素中间体及其制备方法与泰拉霉素的制备方法
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ,インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
SI3027634T1 (sl) * 2013-07-31 2018-10-30 Farma Grs, D.O.O. Proces za pripravo tulatromicina
CN103497227B (zh) * 2013-09-13 2015-09-30 青岛科技大学 一种泰拉菌素中间体的制备方法
CN104725446B (zh) * 2015-03-26 2017-10-27 宁夏泰瑞制药股份有限公司 一种从泰拉霉素粗品中分离泰拉霉素a和泰拉霉素b的方法
CN104861018A (zh) * 2015-06-17 2015-08-26 瑞普(天津)生物药业有限公司 一种泰拉菌素的制备方法
CN105646617A (zh) * 2016-01-21 2016-06-08 杭州海尔希畜牧科技有限公司 一种制备泰拉霉素的方法
FR3048612B1 (fr) * 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
CN106046077B (zh) * 2016-08-04 2019-07-26 湖北美天生物科技股份有限公司 一种泰拉霉素a的合成方法
CN108003207B (zh) 2017-12-19 2019-05-10 海门慧聚药业有限公司 制备泰拉霉素的方法
CN111087433B (zh) * 2018-10-23 2023-03-21 湖北美天生物科技股份有限公司 一种泰拉霉素中间体的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5226958A (en) * 1991-04-11 1993-07-13 Pacemark, Inc. Sealant for pneumatic inner tubes and tubeless tires
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5441939A (en) * 1994-03-04 1995-08-15 Pfizer Inc. 3"-desmethoxy derivatives of erythromycin and azithromycin
HN1998000086A (es) 1997-06-11 1999-03-08 Pfizer Prod Inc Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
UA70972C2 (uk) 1998-11-20 2004-11-15 Пфайзер Продактс Інк. 13-членні азаліди і їх застосування як антибіотиків

Also Published As

Publication number Publication date
KR20010013632A (ko) 2001-02-26
DK0988310T3 (da) 2003-12-15
LU91076I9 (en) 2018-07-02
HRP980314A2 (en) 1999-04-30
DE122004000018I1 (de) 2004-09-30
NZ514871A (en) 2003-08-29
HK1028048A1 (en) 2001-02-02
EP0988310B1 (en) 2003-10-01
PA8452201A1 (es) 2000-05-24
ZA985017B (en) 1999-12-17
ATE251173T1 (de) 2003-10-15
HUS1200028I1 (hu) 2016-08-29
US20040023896A1 (en) 2004-02-05
US20040180842A1 (en) 2004-09-16
PL337505A1 (en) 2000-08-28
SK168399A3 (en) 2000-11-07
UA67744C2 (uk) 2004-07-15
CA2293823A1 (en) 1998-12-17
NO996106D0 (no) 1999-12-10
EA199901015A1 (ru) 2000-06-26
YU58699A (US06559137-20030506-C00182.png) 2002-08-12
BRPI9810519B1 (pt) 2012-02-22
GT199800077A (es) 1999-12-02
AU7347598A (en) 1998-12-30
ID22992A (id) 1999-12-23
US6777393B2 (en) 2004-08-17
EP0988310B9 (en) 2006-03-08
BRPI9810519A (pt) 2000-09-19
IL132809A0 (en) 2001-03-19
DE69818665D1 (de) 2003-11-06
OA11224A (en) 2003-07-16
FR04C0013I1 (US06559137-20030506-C00182.png) 2004-06-11
AU749816B2 (en) 2002-07-04
JP2000514098A (ja) 2000-10-24
US6936592B2 (en) 2005-08-30
CN101691390A (zh) 2010-04-07
CN1243766C (zh) 2006-03-01
CN1172947C (zh) 2004-10-27
BG103945A (en) 2000-07-31
HUP0002209A2 (hu) 2000-12-28
JP3315704B2 (ja) 2002-08-19
CA2293823C (en) 2004-02-17
LU91076I2 (fr) 2004-07-05
HN1998000086A (es) 1999-03-08
HK1088014A1 (en) 2006-10-27
TNSN98082A1 (fr) 2005-03-15
KR100396168B1 (ko) 2003-08-27
SI0988310T1 (en) 2004-02-29
DE69818665T2 (de) 2004-04-29
CN1566129A (zh) 2005-01-19
PT988310E (pt) 2003-12-31
NO316911B1 (no) 2004-06-21
CZ298556B6 (cs) 2007-11-07
AP9801255A0 (en) 1998-06-30
DZ2514A1 (fr) 2003-02-01
HRP980314B1 (en) 2004-04-30
BG64391B1 (bg) 2004-12-30
EA002441B1 (ru) 2002-04-25
ME00876B (me) 2012-06-20
IS5252A (is) 1999-11-16
AR013086A1 (es) 2000-12-13
US6420536B1 (en) 2002-07-16
CN1259136A (zh) 2000-07-05
AP1231A (en) 2003-12-11
TW472060B (en) 2002-01-11
CO4950611A1 (es) 2000-09-01
UY25040A1 (es) 2000-09-29
US20020061858A1 (en) 2002-05-23
HUP0002209A3 (en) 2003-05-28
IS1998B (is) 2005-03-15
JP2002316933A (ja) 2002-10-31
DE122004000018I2 (de) 2011-01-13
NL300150I1 (nl) 2004-08-02
CN1793155B (zh) 2010-05-12
MY123354A (en) 2006-05-31
WO1998056802A1 (en) 1998-12-17
BRPI9810519B8 (pt) 2022-11-16
EP0988310A1 (en) 2000-03-29
SK284171B6 (sk) 2004-10-05
PE79699A1 (es) 1999-08-25
MA24564A1 (fr) 1998-12-31
CN1793155A (zh) 2006-06-28
HU228005B1 (en) 2012-08-28
EG24081A (en) 2008-05-11
NO996106L (no) 2000-02-10
FR04C0013I2 (US06559137-20030506-C00182.png) 2005-10-21
NZ500660A (en) 2002-03-01
CZ442199A3 (cs) 2000-07-12
ES2205487T3 (es) 2004-05-01
NL300150I2 (nl) 2004-09-01
HK1068893A1 (en) 2005-07-29
PL191601B1 (pl) 2006-06-30

Similar Documents

Publication Publication Date Title
RS49675B (sr) 4"supstituisani-9-deokso-9a-aza-9a- homoeritromicin a derivati
CO4950584A1 (es) Derivados de macrolidos c-4´´ sustituidos
YU51092A (sh) Novi derivati tiopiranopirola i njihovo dobijanje
EA200000731A1 (ru) Альфа-аминоамидные производные, полезные в качестве анальгетических агентов
RS49836B (sr) Postupci i intermedijeri za dobijanje anti-kancernih jedinjenja
FR2654104B1 (fr) Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
YU47099B (sh) Postupak za dobijanje makrolidnih jedinjenja
IE902182L (en) Tricyclic compounds; pharmaceutical compositions
HUP0203108A2 (hu) Pikornavírus ellenes hatású vegyületek, valamint ezeket tartalmazó gyógyászati készítmények és a vegyületek előállítására alkalmazott közbenső termékek
ATE142641T1 (de) Neue peptid-verbindungen und verfahren zur herstellung davon
AR053835A1 (es) Tetrahidropiridoazepin - 8 - onas como moduladores del receptor de dopamina d2 y compuestos relacionados para el tratamiento de la esquizofrenia y otros trastornos del snc, composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos.
NO20001871L (no) Nye 3,6-hemiacetaler fra klassen 9a-azalider
SE7602122L (sv) Nya piperazinyliminorifamyciner och sett att framstella desamma
SE8603098L (sv) Poly-4-aminopyrrol-2-karboxamidoderivat och forfarande for deras framstellning
DE69311118D1 (de) Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung
PE20020599A1 (es) Derivados de acido amino-furan-2-il-acetico sustituido o de acido amino-tien-2-il-acetico sustituido, procedimiento para su preparacion, medicamentos que los contienen, uso de estos compuestos para la preparacion de medicamentos para el tratamiento d
DE60043293D1 (de) VAKUOLAR-TYP (H+)-ATPase-HEMMENDE VERBINDUNGEN, ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN
ES2064941T3 (es) Nuevas acil-benzoxazolinonas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
JPS55120575A (en) Cis-2,3-epoxy-4-lower alkoxyphenylbutanoic acid derivative and its production
HUP9603498A2 (hu) Indolszármazékok és e vegyületeket tartalmazó gyógyászati készítmények
MX2023004137A (es) Compuestos aromaticos sustituidos y composiciones farmaceuticas de los mismos.
KR900014394A (ko) 비페닐 유도체 및 이의 제조방법
DE69011235D1 (de) Derivate von N-(Vincristinyl-23) und N-(Noranhydro-5-vinblastinyl-23) von Amino-1-methylphosphonsäure, ihre Verfahren zur Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
JPS56131551A (en) Tyrosine derivative and medicinal use
FI813139L (fi) Nya kefalosporin foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel